Our findings demonstrate significant alterations in circulating levels of FGF19, FGF21, leptin, irisin, and adiponectin, providing evidence that severe obesity is associated with dysregulated organokine networks that contribute to liver disease development and progression. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.